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Aim:		We	report	two	cases	with	an	atypical	deletion	located	in	the	22q11.2	region,	to	
elucidate	the	role	of	TBX1	haploinsufficiency	in	the	facial	dysmorphology	in	22q11DS.	
	
Method:	 In	 this	 prospective	 study,	 a	 family	 presented	 with	 velopharyngeal	 insufficiency,	
inherited	in	an	autosomal	dominant	way.	A	small	atypical	22q11.2	deletion	was	detected	by	
microarray-CGH.	Sanger	Sequencing	 indicated	a	deletion	of	the	first	 five	exons	of	TBX1.	 In	
silico	analysis	using	‘SIFT	InDel’	indicated	that	the	partly	deleted	TBX1	is	no	longer	functional.	
Phenotypically,	they	did	not	share	any	of	the	other	characteristics	of	the	22q11.2DS	and	facial	
features	were	unremarkable.	
Secondly,	a	boy	aged	14	was	referred	to	the	Department	for	Human	Genetics	for	refractory	
epilepsy	 and	 mild	 intellectual	 disability.	 Microarray-CGH	 and	 Sanger	 sequencing	 showed	
another	atypical	22q11.2	deletion	including	CRKL,	but	not	containing	the	TBX1	gene.	The	boy	
had	facial	features	reminiscent	of	the	22q11DS.		
All	study	subjects	underwent	3D	morphometric	facial	analysis,	with	comparison	to	faces	of	
patients	with	a	complete	3Mb	22q11.2	deletion.		
 
Results:	Objective	3D	analysis	confirmed	that	the	affected	family	members	with	the	TBX1	
deletion	did	not	have	the	characteristic	facial	features	of	22Q11DS,	whereas	the	14	year-old	
male	with	an	atypical	deletion	including	CRKL	did.	
	
Conclusion:	Based	on	these	observations,	we	can	conclude	that	the	craniofacial	phenotype	
in	22q11DS	is	not	solely	explained	by	TBX1	haploinsufficiency.		CRKL	is	alternative	candidate	
gene	for	this	phenotype.		
	
	
